• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension.

作者信息

Spoladore Roberto, Maranta Francesco, Fragasso Gabriele

机构信息

Heart Failure Clinic, Istituto Scientifico San Raffaele, Via Olgettina 60, 20132 Milano, Italy.

Heart Failure Clinic, Istituto Scientifico San Raffaele, Via Olgettina 60, 20132 Milano, Italy.

出版信息

Indian Heart J. 2017 May-Jun;69(3):417. doi: 10.1016/j.ihj.2017.01.002. Epub 2017 Jan 12.

DOI:10.1016/j.ihj.2017.01.002
PMID:28648446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5485400/
Abstract
摘要

相似文献

1
Pathophysiological mechanisms should be taken into account and guide the treatment of essential arterial hypertension.应考虑病理生理机制并指导原发性高血压的治疗。
Indian Heart J. 2017 May-Jun;69(3):417. doi: 10.1016/j.ihj.2017.01.002. Epub 2017 Jan 12.
2
From 'essential' hypertension to intensive blood pressure lowering: the pros and cons of lower target values.从“原发性”高血压到强化降压：更低目标值的利弊
Eur Heart J. 2017 Nov 21;38(44):3258-3271. doi: 10.1093/eurheartj/ehx643.
3
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.如何提高抗高血压药物治疗的有效性和依从性：二氢吡啶类钙通道阻滞剂在高血压治疗中的核心作用
High Blood Press Cardiovasc Prev. 2018 Mar;25(1):25-34. doi: 10.1007/s40292-017-0242-z. Epub 2017 Dec 2.
4
Precision Medicine.精准医学
Circ Res. 2019 Mar 29;124(7):987-989. doi: 10.1161/CIRCRESAHA.119.314403.
5
Monographic issue of pharmacological research on hypertension.高血压药理学研究专刊。
Pharmacol Res. 2018 Aug;134:221-222. doi: 10.1016/j.phrs.2018.06.028. Epub 2018 Jun 28.
6
Prescription status of diuretics for essential hypertension in a Japanese population.日本人群中用于原发性高血压的利尿剂的处方情况。
Hypertens Res. 2021 Oct;44(10):1359-1361. doi: 10.1038/s41440-021-00688-0. Epub 2021 Jul 16.
7
Changes in Kidney Function in a Population With Essential Hypertension in Real Life Settings.现实生活环境中原发性高血压人群的肾功能变化
Iran J Kidney Dis. 2017 May;11(3):192-200.
8
Salt and essential hypertension: pathophysiology and implications for treatment.盐与原发性高血压：病理生理学及治疗意义
J Am Soc Hypertens. 2017 Jun;11(6):385-391. doi: 10.1016/j.jash.2017.04.006. Epub 2017 Apr 14.
9
["Individualized antihypertensive therapy. Diuretics degraded as hypertension drugs (interview by Dr. med. Jochen Aumiller)].个体化抗高血压治疗。利尿剂作为高血压药物的降级使用（医学博士约亨·奥米勒访谈）
MMW Fortschr Med. 2011 Dec 15;153(51-52):21.
10
[Essential hypertension: Definitions, hemodynamic, clinical and therapeutic review].[原发性高血压：定义、血流动力学、临床及治疗综述]
Presse Med. 2019 Jan;48(1 Pt 1):19-28. doi: 10.1016/j.lpm.2018.11.017. Epub 2019 Jan 18.

本文引用的文献

1
Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial Hypertension.原发性高血压治疗性药物干预的病理生理机制及其关联
Adv Exp Med Biol. 2017;956:37-59. doi: 10.1007/5584_2016_169.
2
Diuretics in primary hypertension - Reloaded.原发性高血压中的利尿剂——再审视
Indian Heart J. 2016 Sep-Oct;68(5):720-723. doi: 10.1016/j.ihj.2016.08.013. Epub 2016 Sep 10.
3
Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.氢氯噻嗪与吲达帕胺和氯噻酮的直接比较：降压和代谢作用。
Hypertension. 2015 May;65(5):1041-6. doi: 10.1161/HYPERTENSIONAHA.114.05021. Epub 2015 Mar 2.
4
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).2014 年成人高血压管理的循证指南：第八届联合国家委员会（JNC 8）任命的专家组报告。
JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427.
5
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理指南：欧洲高血压学会（ESH）和欧洲心脏病学会（ESC）动脉高血压管理特别工作组
Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14.
6
Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial.放血疗法诱导的体内铁储存减少对代谢综合征的影响：一项随机临床试验的结果。
BMC Med. 2012 May 30;10:54. doi: 10.1186/1741-7015-10-54.
7
Back to past leeches: repeated phlebotomies and cardiovascular risk.回到过去的蚂蟥：反复放血与心血管风险。
BMC Med. 2012 May 30;10:53. doi: 10.1186/1741-7015-10-53.
8
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study.坎地沙坦与氢氯噻嗪对肥胖高血压个体血压、胰岛素敏感性及交感神经驱动的比较效应：CROSS研究结果
J Hypertens. 2003 Sep;21(9):1761-9. doi: 10.1097/00004872-200309000-00027.
9
The ALLHAT report: a case of information and misinformation.抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）报告：一则信息与错误信息的案例
J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):9-13. doi: 10.1111/j.1524-6175.2003.02287.x.
10
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局：抗高血压和降脂治疗预防心脏病发作试验（ALLHAT）
JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.